Biogen Inc. buy Needham & Company LLC
Start price
25.07.23
/
50%
€242.80
Target price
25.07.24
€290.08
Performance (%)
-13.55%
End price
26.07.24
€209.90
Summary
This prediction ended on 26.07.24 with a price of €209.90. The prediction for Biogen Inc. disappointed with a performance of -13.55%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biogen Inc. | 1.133% | 1.133% | -25.831% |
iShares Core DAX® | 0.347% | 2.173% | 18.599% |
iShares Nasdaq 100 | 0.715% | 0.138% | 26.542% |
iShares Nikkei 225® | 1.522% | 2.003% | 13.220% |
iShares S&P 500 | 0.631% | 1.633% | 25.009% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $320.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten